These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9843356)

  • 1. Laboratory-based surveillance for rotavirus--United States, July 1997-June 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(45):978-80. PubMed ID: 9843356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-based surveillance for rotavirus -- United States, July 1996-June 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(46):1092-4. PubMed ID: 9385879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed onset and diminished magnitude of rotavirus activity--United States, November 2007-May 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(25):697-700. PubMed ID: 18583958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in rotavirus after vaccine introduction--United States, 2000-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(41):1146-9. PubMed ID: 19847149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.
    Patel MM; Tate JE; Selvarangan R; Daskalaki I; Jackson MA; Curns AT; Coffin S; Watson B; Hodinka R; Glass RI; Parashar UD
    Pediatr Infect Dis J; 2007 Oct; 26(10):914-9. PubMed ID: 17901797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccine, live, oral, tetravalent (RotaShield).
    Hochwald C; Kivela L
    Pediatr Nurs; 1999; 25(2):203-4, 207. PubMed ID: 10532018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):577-81. PubMed ID: 10428095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1999 Mar; 48(RR-2):1-20. PubMed ID: 10219046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States.
    Flores AR; Szilagyi PG; Auinger P; Fisher SG
    Pediatrics; 2010 Feb; 125(2):e191-8. PubMed ID: 20100749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.
    Cortese MM; Tate JE; Simonsen L; Edelman L; Parashar UD
    Pediatr Infect Dis J; 2010 Jun; 29(6):489-94. PubMed ID: 20354464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RotaTeq vaccine adverse events and policy considerations.
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: respiratory syncytial virus activity -- United States, 1997-98 season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Dec; 46(49):1163-5. PubMed ID: 9408044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.